About neoSurgical
neoSurgical is a Healthcare company based in Galway (Ireland) founded in 2008, and was acquired by Sharp Fluidics in April 2020. Laparoscopic surgical instruments for access, retraction, and closure are provided. neoSurgical has raised $13.26 million across 3 funding rounds from investors including Enterprise Ireland, Sharp Fluidics and Targeted Technology. neoSurgical was last valued at $21 million in April 2015. The company was acqui-hired. Its focus areas include Life Sciences, Surgical Instruments, Surgical Access and Closure and Laparoscopic Access Device. Its legal entity is NEOSURGICAL LIMITED.
Company details
neoSurgical was founded in 2008 in Galway, Ireland, as a provider of medical devices in the surgical sector. Laparoscopic instruments are developed and supplied, with the lead product neoClose utilized for port site closure after abdominal procedures. Additional devices support access and retraction during laparoscopic surgeries. Operations focus on instrument innovation for minimally invasive techniques in healthcare settings.
- Headquarters Galway, Ireland
- Stage Acquired
- SectorsHealthcare
- Website neosurgical.com
- Social LinkedIn X
- Acquired by Sharp Fluidics (Apr 2020)
- Legal Name Neosurgical Limited
- Total Equity Funding$13.26M (USD)
in 3 rounds
- Latest Funding Round$5.5M (USD), Series B
Jun 2017
- InvestorsEnterprise Ireland
& 3 more
- Acquired bySharp Fluidics
(Apr 2020)
Funding Insights of neoSurgical
neoSurgical has successfully raised a total of $13.26M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.5 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.26M
- Total Rounds 3
- Last Round Series B — $5.5M
- First Round $2.16M
(Sep 2011)
- Investors Count 3
All 3 funding rounds of neoSurgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $5.5M | Series B | – | – | |
| Apr 2015 | $5.6M | Series B | $21M | – | – |
| Sep 2011 | $2.16M | Series A | – | Kernel Capital |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2015 | $21M | •••••••• |
Last known valuation $21M (Apr 2015). 4 investors in total: 4 institutional.
Investors in neoSurgical
neoSurgical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, Sharp Fluidics and Targeted Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage investments in medical and life science technologies are made by Targeted Technology. | targetedtech.com | San Antonio, United States | ||
VC firm investing in the UK and the US | kernel-capital.com | Cork, Ireland | ||
Support is provided to Irish manufacturing and service sector businesses. | 1998 | enterprise-ireland.com | Dublin, Ireland | |
Suture needle management systems are developed for safe surgical infusion. | 2014 | sharpfluidics.com | San Francisco, United States |
Investor details for neoSurgical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of neoSurgical
5 dated milestones of neoSurgical across 12 years, from founding to its latest funding, stage changes and deals.
- Founded neoSurgical is founded.
- Funding First funding round of $2.2M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $5.5M.
- Exit Acquired by Sharp Fluidics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neosurgical
Complete news archive for neoSurgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about neoSurgical
neoSurgical was founded in 2008 and raised its 1st funding round 3 years after it was founded.
neoSurgical is headquartered in Galway, Ireland.
neoSurgical is a funded company, having raised a total of $13.26M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.16M, raised on Sep 2011.
neoSurgical was founded in 2008 in Galway, Ireland, as a provider of medical devices in the surgical sector. Laparoscopic instruments are developed and supplied, with the lead product neoClose utilized for port site closure after abdominal procedures. Additional devices support access and retraction during laparoscopic surgeries. Operations focus on instrument innovation for minimally invasive techniques in healthcare settings.
neoSurgical has 4 investors. Key investors include Enterprise Ireland, Sharp Fluidics, Targeted Technology, and Kernel Capital.
The valuation of neoSurgical is $21M as of Apr 2015.
neoSurgical operates through Neosurgical Limited.
Yes. neoSurgical was acquired by Sharp Fluidics in April 2020.